Label: Zepbound-tirzepatide injection, solution zepbound-tirzepatide injection, solution, DailyMed (2025) Zepbound, Food and Drug Administration (2025) Adverse events related to tirzepatide, J Endocr Soc (2023) Medically accurate: SingleCares Medical Review Board analyzes all of our content to confirm its in line with current medical advice
Who Should Avoid It Known copper sensitivity or Wilson's disease Active skin infections at application site Pregnancy or breastfeeding (injectable) Stop Right Away If You Notice Severe skin irritation, burning, or persistent redness Allergic reactions (rash, swelling, difficulty breathing) Unusual skin discoloration or staining Persistent metallic taste (injectable) Worsening of skin condition after 4-6 weeks Milder Signs to Watch For How Long Should a GHK-Cu Cycle Last
BCBS FEP Coverage for Teen Depression Treatment The Blue Cross Blue Shield FEP provides some level of coverage for teen depression treatment, ensuring access to the mental health services needed to treat this condition
Looking to join a support group
Safety: What is and is not known Animal safety data A 2020 preclinical safety evaluation by Xu and colleagues in Regulatory Toxicology and Pharmacology examined BPC-157 across multiple species mice, rats, rabbits, and dogs and reported no serious toxicity, no genotoxicity, and no embryotoxicity at doses evaluated